Hyperfine (HYPR) Projected to Post Quarterly Earnings on Tuesday

Hyperfine (NASDAQ:HYPR) is expected to announce its Q1 2026 results after the market closes on Tuesday, May 12th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $3.54 million for the quarter. Parties can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Tuesday, May 12, 2026 at 4:30 PM ET.

Hyperfine (NASDAQ:HYPR) last posted its quarterly earnings results on Wednesday, March 18th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.02. Hyperfine had a negative net margin of 262.29% and a negative return on equity of 95.09%. The company had revenue of $5.29 million for the quarter, compared to analyst estimates of $5.30 million.

Hyperfine Trading Down 4.7%

Shares of NASDAQ HYPR traded down $0.09 during midday trading on Tuesday, hitting $1.73. The company’s stock had a trading volume of 508,887 shares, compared to its average volume of 535,316. The stock has a fifty day moving average price of $1.19 and a 200 day moving average price of $1.14. The firm has a market capitalization of $168.98 million, a price-to-earnings ratio of -3.92 and a beta of 1.42. Hyperfine has a one year low of $0.53 and a one year high of $2.22.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on HYPR shares. BTIG Research started coverage on shares of Hyperfine in a research note on Wednesday, April 29th. They issued a “buy” rating and a $2.00 price target for the company. Lake Street Capital increased their price target on shares of Hyperfine from $2.00 to $2.50 and gave the company a “buy” rating in a research report on Thursday, March 19th. Weiss Ratings restated a “sell (d-)” rating on shares of Hyperfine in a report on Tuesday, April 21st. Finally, Zacks Research upgraded shares of Hyperfine to a “hold” rating in a report on Thursday, March 19th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Hyperfine has an average rating of “Hold” and a consensus price target of $1.59.

Insider Buying and Selling at Hyperfine

In other Hyperfine news, COO Thomas Teisseyre sold 24,188 shares of the firm’s stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total transaction of $29,267.48. Following the sale, the chief operating officer owned 354,648 shares in the company, valued at approximately $429,124.08. This trade represents a 6.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Brett Hale sold 24,188 shares of the firm’s stock in a transaction that occurred on Monday, March 23rd. The stock was sold at an average price of $1.21, for a total transaction of $29,267.48. Following the sale, the chief financial officer owned 275,812 shares in the company, valued at approximately $333,732.52. The trade was a 8.06% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 26.33% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HYPR. EP Wealth Advisors LLC bought a new position in shares of Hyperfine in the fourth quarter worth about $34,000. Millennium Management LLC bought a new position in Hyperfine during the 4th quarter worth about $55,000. Cerity Partners LLC purchased a new stake in shares of Hyperfine during the fourth quarter valued at about $59,000. XTX Topco Ltd lifted its position in shares of Hyperfine by 47.9% during the fourth quarter. XTX Topco Ltd now owns 80,735 shares of the company’s stock valued at $79,000 after buying an additional 26,165 shares during the last quarter. Finally, Bridgeway Capital Management LLC lifted its position in shares of Hyperfine by 50.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 119,700 shares of the company’s stock valued at $117,000 after buying an additional 40,000 shares during the last quarter. Institutional investors own 15.03% of the company’s stock.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.